“…Cbl is converted into methyl-Cbl in the cytoplasm and 5'-deoxyadenosyl-Cbl in mitochondria and these two forms are utilized as coenzyme by methionine synthase and methylmalonyl-CoA mutase respectively. The essential role of TCII in the cellular delivery of Cbl for intracellular utilization is borne out by the fact that an inherited lack of TCII leads to intracellular Cbl deficiency, resulting in megaloblastic anaemia, impaired immune defence, neurological disorders (Hakimi et al, 1971;Hitzig et al, 1974;Burman et al, 1979;Hurani et al, 1979;Hall, 1981;Frater-Schroder et al, 1981;Thomas et al, 1982) and, in extreme cases, death if not treated with Cbl. Hereditary TCII deficiency is a rare autosomal recessive disorder (Hakimi et al, 1971) and three forms of TCII defect have been reported (Frater-Schroder, 1983). In the most common, immunoreactive TCII is absent from the plasma of TCIIdeficient patients.…”